WeVote
Log In

Bill

Bill

HB 5162

Controlled substances: schedules; scheduling of certain controlled substances; modify. Amends sec. 7204 of 1978 PA 368 (MCL 333.7204).

2025-2026 Regular Session Introduced by Alicia St. Germaine and 1 co-sponsor

HB 5162 trims Michigan’s federal scheduling response from 91 to 30 days, forcing a Board of Pharmacy decision and public rationale within 30 days to align state law faster.

referred to second reading
#controlledsubstances:schedules #stateagencies(existing):boardsandcommissions
0
WeVote Research Nonpartisan
Bill Summary · HB 5162

HB 5162 — Controlled substances: schedules; modify scheduling timeframe

Status: Introduced (filed 3/14/2025); latest electronic reproduction 10/29/2025; referred to House Health Policy Committee on 10/29/2025
Sponsors: Rep. Alicia St. Germaine (primary), Rep. Jaime Greene (co‑sponsor)
Statute amended: 1978 PA 368 (Public Health Code), sec. 7204 (MCL 333.7204)

Purpose / intent

House Bill 5162 shortens the time Michigan has to act after the federal government redesignates, reschedules, or deletes a controlled substance. The bill accelerates Michigan’s response window from 91 days to 30 days for holding a Board of Pharmacy meeting to determine whether to adopt the federal scheduling change and for publishing reasons if the state declines to follow the federal action.

Key provisions

  • Amends MCL 333.7204 to replace the current 91‑day deadlines with 30‑day deadlines in two places:
    • The administrator (acting with the Board of Pharmacy) must hold a board meeting “not more than 30 days after notice is received” to determine whether the substance should be similarly scheduled under state law.
    • If the administrator decides not to similarly schedule the substance, the administrator must publish the reasons for that decision “not more than 30 days after that decision is made.”
  • Text change is limited to shortening the statutory timeframes; no other changes to scheduling authority or procedures are proposed.

Who is affected

  • Michigan Board of Pharmacy / the “administrator” responsible for convening the board.
  • Regulated parties (pharmacies, prescribers, distributors, manufacturers) and law enforcement, who may see quicker alignment (or faster formal rejection) of federal scheduling changes at the state level.
  • Patients and public health entities may experience more rapid changes in legal status, prescribing rules, and enforcement for individual substances.

Procedural / timeline notes

  • Bill introduced and referred to committee in 2025; latest reproduced 10/29/2025.
  • Amends an existing provision of the Public Health Code previously amended (2012 PA 182).

Fiscal impact

  • House Fiscal Agency: no fiscal impact on state or local government.

Potential effects (neutral observation)

  • Faster timelines could improve Michigan’s ability to align with federal controlled‑substance schedules promptly, reducing gaps between federal and state control.
  • The shorter window may compress time available for deliberation, stakeholder input, or legal/medical review before the Board issues a determination or publishes its reasons.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.